260 related articles for article (PubMed ID: 15372410)
1. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
Negri AL
J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases.
Eitner F; Floege J
Curr Opin Investig Drugs; 2005 Mar; 6(3):255-61. PubMed ID: 15816501
[TBL] [Abstract][Full Text] [Related]
3. The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function.
Klahr S
J Nephrol; 2003; 16(2):179-85. PubMed ID: 12768064
[TBL] [Abstract][Full Text] [Related]
4. [BMP-7 (Bone morphogenetic protein-7): a future treatment for chronic renal failure?].
Niksic L; Martin PY
Rev Med Suisse; 2005 Feb; 1(8):568-70, 572-3. PubMed ID: 15794307
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.
Morrissey J; Hruska K; Guo G; Wang S; Chen Q; Klahr S
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S14-21. PubMed ID: 11792757
[TBL] [Abstract][Full Text] [Related]
6. Relaxin: an endogenous renoprotective factor?
Hewitson TD; Samuel CS
Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
[TBL] [Abstract][Full Text] [Related]
7. Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
Dussaule JC; Chatziantoniou C
Cell Death Differ; 2007 Jul; 14(7):1343-9. PubMed ID: 17396129
[TBL] [Abstract][Full Text] [Related]
8. Ramping up endogenous defences against chronic kidney disease.
Eddy AA
Nephrol Dial Transplant; 2006 May; 21(5):1174-7. PubMed ID: 16574685
[No Abstract] [Full Text] [Related]
9. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
Takakuta K; Fujimori A; Chikanishi T; Tanokura A; Iwatsuki Y; Yamamoto M; Nakajima H; Okada M; Itoh H
Eur J Pharmacol; 2010 Mar; 629(1-3):118-24. PubMed ID: 20006961
[TBL] [Abstract][Full Text] [Related]
10. The effects of rapamycin in the progression of renal fibrosis.
Damião MJ; Bertocchi AP; Monteiro RM; Gonçalves GM; Cenedeze MA; Feitoza CQ; Marques GD; Giannocco G; Mazzali M; Teixeira VP; Dos Reis MA; Pacheco-Silva A; Câmara NO
Transplant Proc; 2007 Mar; 39(2):457-9. PubMed ID: 17362758
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.
Mizuno S; Kurosawa T; Matsumoto K; Mizuno-Horikawa Y; Okamoto M; Nakamura T
J Clin Invest; 1998 May; 101(9):1827-34. PubMed ID: 9576745
[TBL] [Abstract][Full Text] [Related]
12. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.
Liu Y
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F7-16. PubMed ID: 15180923
[TBL] [Abstract][Full Text] [Related]
14. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
[TBL] [Abstract][Full Text] [Related]
16. Progression in chronic kidney disease.
Eddy AA
Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocyte growth factor and kidney].
Esposito C; Fasoli G; Rampino T; Dal Canton A
G Ital Nefrol; 2006; 23(4):381-8. PubMed ID: 17063438
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.
Zeisberg M; Bottiglio C; Kumar N; Maeshima Y; Strutz F; Müller GA; Kalluri R
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1060-7. PubMed ID: 12915382
[TBL] [Abstract][Full Text] [Related]
19. The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model.
Brook NR; Waller JR; Bicknell GR; Nicholson ML
Transplant Proc; 2005; 37(1):130-3. PubMed ID: 15808571
[TBL] [Abstract][Full Text] [Related]
20. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
Gaedeke J; Boehler T; Budde K; Neumayer HH; Peters H
Nephrol Dial Transplant; 2005 Feb; 20(2):319-28. PubMed ID: 15673690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
